505-双特异性多肽-纳米酶偶联物抗肿瘤研究 episode artwork

EPISODE · Feb 14, 2026 · 20 MIN

505-双特异性多肽-纳米酶偶联物抗肿瘤研究

from 聊聊Sci

这项研究介绍了一种名为 BsPNEC 的双特异性肽-纳米酶结合物,旨在克服癌症免疫治疗中的耐药性。研究人员首先通过结构优化设计出一种能同时阻断 PD-L1(恢复 T 细胞功能)和 CXCR1/2(减少免疫抑制细胞浸润)的双功能多肽 qGA。随后将其与 Fe3O4 纳米酶 结合,利用纳米酶产生的活性氧激活 cGAS-STING 通路,从而进一步增强 T 细胞对肿瘤的攻击。实验证明,该平台在耐药性胰腺癌等模型中展现了显著的治疗效果,并集成了 磁共振成像(MRI) 示踪功能。这种多模态策略通过重塑肿瘤微环境,为协同增强癌症免疫疗法提供了新途径。References: Chen D, Xu R, Ye X, et al. Design of a bispecific peptide-nanozyme conjugate for cancer immunotherapy[J]. Cell Reports Medicine, 2026.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Feb 14, 2026

Embed this episode

Ready to play

505-双特异性多肽-纳米酶偶联物抗肿瘤研究

0:00 20:16

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 20 minutes long.

When was this 聊聊Sci episode published?

This episode was published on February 14, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!